February 24, 2026

Galapagos NV (GLPG) Stock Analysis: Navigating a Challenging Biotech Landscape with Innovative CAR-T Therapies

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, is making strides in the healthcare sector by focusing on cutting-edge therapies in oncology and immunology. The company has a significant market..

CONMED Corporation (CNMD) Stock Analysis: Navigating Growth in Medical Devices with a 4.45% Upside

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector, specializes in the medical device industry. As a U.S.-based company with a market capitalization of $1.41 billion, CONMED is..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Evaluating a 26% Potential Upside with Robust Revenue Growth

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. Established in 2013 and headquartered in Orange,..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring a 32.56% Upside Potential Driven by Strong Revenue Growth

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, offers an intriguing investment case with a compelling potential upside of 32.56%, according to recent analyst ratings. Specializing..

Premier, Inc. (PINC) Stock Analysis: Navigating the Healthcare Sector with a High Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare improvement sector, offers a unique value proposition for investors amid the dynamic healthcare industry. With a market capitalization of $2.34..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating a 22.75% Potential Upside

For investors with an eye on the healthcare sector, Warby Parker Inc. (NYSE: WRBY) presents a compelling narrative of innovation and growth, albeit with its share of challenges. Positioned within..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a 5.10% Dividend Yield Amidst Challenging Fundamentals

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $2.5 billion, this U.S.-based company..

Perrigo Company plc (PRGO) Investor Outlook: A High Dividend Yield Amidst a Challenging Valuation Landscape

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, emerges as a key provider of over-the-counter health and wellness solutions across the globe. With a market capitalization..

Kymera Therapeutics (KYMR) Stock Analysis: Assessing a 31.98% Potential Upside in the Biotech Arena

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector, bringing innovative solutions to some of the most challenging immunology and inflammatory diseases. With a market capitalization of..

GeneDx Holdings Corp. (WGS)

⚠️ No article content returned.

..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Healthcare Innovator with 32.92% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a promising player in the biotechnology sector, is capturing the attention of investors with its innovative focus on eye care therapeutics and infectious disease prevention...

LivaNova PLC (LIVN) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 6.8% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector specializing in medical devices, continues to capture investor attention with its robust growth prospects and strategic market positioning. Headquartered..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Powerhouse with 9.63% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a promising player in the biotechnology sector, is capturing investor attention with its robust pipeline of therapies targeting rare and orphan diseases. Headquartered in Foster..

Certara, Inc. (CERT) Stock Analysis: Unraveling the 90.68% Upside Potential

Investors seeking opportunities in the healthcare sector should take a closer look at Certara, Inc. (NASDAQ: CERT), a pivotal player in the health information services industry. With a market capitalization..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: A 13.45% Upside Potential in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is carving a niche for itself in the healthcare landscape with its specialized focus on medical instruments and supplies. Headquartered in Burlington, Massachusetts, LeMaitre Vascular..

Metsera, Inc. (MTSR) Stock Report: Evaluating the Biotech Player’s -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a promising player in the biotechnology sector, has garnered attention from investors due to its innovative approach to tackling obesity and related diseases. As a clinical-stage..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Unveiling a Potential Upside of 179.68%

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out as a compelling investment opportunity in the healthcare sector, specifically within the realm of drug manufacturers focused on specialty and generic pharmaceuticals. Based..

Merus N.V. (MRUS) Stock Analysis: Potential Upside in the Biotech Sector

Merus N.V. (NASDAQ: MRUS), a Dutch biotechnology company, is making waves in the healthcare sector with its innovative approach to immuno-oncology therapies. With a strategic focus on developing bispecific antibody..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a Remarkable 151% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) presents a compelling opportunity for investors in the biotechnology sector, exhibiting a notable potential upside of 151.22% based on the average target price set by..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds